Cargando…
The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi
BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gyne...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695797/ https://www.ncbi.nlm.nih.gov/pubmed/29155891 http://dx.doi.org/10.1371/journal.pone.0188379 |
_version_ | 1783280362758078464 |
---|---|
author | Singano, Victor Amberbir, Alemayehu Garone, Daniela Kandionamaso, Christopher Msonko, Jack van Lettow, Monique Kalima, Kondwani Mataka, Yamikani Kawalazira, Gift Mateyu, Gabriel Kwekwesa, Aunex Matengeni, Alfred van Oosterhout, Joep J. |
author_facet | Singano, Victor Amberbir, Alemayehu Garone, Daniela Kandionamaso, Christopher Msonko, Jack van Lettow, Monique Kalima, Kondwani Mataka, Yamikani Kawalazira, Gift Mateyu, Gabriel Kwekwesa, Aunex Matengeni, Alfred van Oosterhout, Joep J. |
author_sort | Singano, Victor |
collection | PubMed |
description | BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. METHODS: We conducted a cross–sectional study in males ≥18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. RESULTS: We enrolled 1,027 men with median age 44 years (IQR: 38–52). The median ART duration was 57 months (IQR: 27–85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7–7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2–7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04–4.25). CONCLUSIONS: The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management. |
format | Online Article Text |
id | pubmed-5695797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-56957972017-11-30 The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi Singano, Victor Amberbir, Alemayehu Garone, Daniela Kandionamaso, Christopher Msonko, Jack van Lettow, Monique Kalima, Kondwani Mataka, Yamikani Kawalazira, Gift Mateyu, Gabriel Kwekwesa, Aunex Matengeni, Alfred van Oosterhout, Joep J. PLoS One Research Article BACKGROUND: Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. METHODS: We conducted a cross–sectional study in males ≥18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. RESULTS: We enrolled 1,027 men with median age 44 years (IQR: 38–52). The median ART duration was 57 months (IQR: 27–85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7–7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2–7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04–4.25). CONCLUSIONS: The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management. Public Library of Science 2017-11-20 /pmc/articles/PMC5695797/ /pubmed/29155891 http://dx.doi.org/10.1371/journal.pone.0188379 Text en © 2017 Singano et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Singano, Victor Amberbir, Alemayehu Garone, Daniela Kandionamaso, Christopher Msonko, Jack van Lettow, Monique Kalima, Kondwani Mataka, Yamikani Kawalazira, Gift Mateyu, Gabriel Kwekwesa, Aunex Matengeni, Alfred van Oosterhout, Joep J. The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title | The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title_full | The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title_fullStr | The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title_full_unstemmed | The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title_short | The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi |
title_sort | burden of gynecomastia among men on antiretroviral therapy in zomba, malawi |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695797/ https://www.ncbi.nlm.nih.gov/pubmed/29155891 http://dx.doi.org/10.1371/journal.pone.0188379 |
work_keys_str_mv | AT singanovictor theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT amberbiralemayehu theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT garonedaniela theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kandionamasochristopher theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT msonkojack theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT vanlettowmonique theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kalimakondwani theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT matakayamikani theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kawalaziragift theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT mateyugabriel theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kwekwesaaunex theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT matengenialfred theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT vanoosterhoutjoepj theburdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT singanovictor burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT amberbiralemayehu burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT garonedaniela burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kandionamasochristopher burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT msonkojack burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT vanlettowmonique burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kalimakondwani burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT matakayamikani burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kawalaziragift burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT mateyugabriel burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT kwekwesaaunex burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT matengenialfred burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi AT vanoosterhoutjoepj burdenofgynecomastiaamongmenonantiretroviraltherapyinzombamalawi |